(MedPage Today) — The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the agency in a JAMA Viewpoint.
Marty Makary, MD, MPH, and Vinay Prasad, MD, MPH, focused on five key areas…
Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/115990
Author :
Publish date : 2025-06-10 15:05:00
Copyright for syndicated content belongs to the linked Source.
